Trial Profile
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapine.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Feb 2013
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- 19 Feb 2013 New trial record